Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 128 entries
Sorted by: Best Match Show Resources per page
Improved Glaucoma Medication Adherence in a Randomized Controlled Trial.

Ophthalmology. Glaucoma

Muir KW, Rosdahl JA, Hein AM, Woolson S, Olsen MK, Kirshner M, Sexton M, Bosworth HB.
PMID: 33892170
Ophthalmol Glaucoma. 2021 Apr 20; doi: 10.1016/j.ogla.2021.04.006. Epub 2021 Apr 20.

PURPOSE: To test the effectiveness of an intervention designed to improve glaucoma medication adherence.DESIGN: Randomized, controlled trial at a Veterans Affairs (VA) eye clinic.PARTICIPANTS: Veterans with medically treated glaucoma who reported poor adherence and their companions if applicable.METHODS: Participants,...

Cite
Muir KW, Rosdahl JA, Hein AM, et al. Improved Glaucoma Medication Adherence in a Randomized Controlled Trial. Ophthalmol Glaucoma. 2021;doi: 10.1016/j.ogla.2021.04.006.
Muir, K. W., Rosdahl, J. A., Hein, A. M., Woolson, S., Olsen, M. K., Kirshner, M., Sexton, M., & Bosworth, H. B. (2021). Improved Glaucoma Medication Adherence in a Randomized Controlled Trial. Ophthalmology. Glaucoma, . https://doi.org/10.1016/j.ogla.2021.04.006
Muir, Kelly W, et al. "Improved Glaucoma Medication Adherence in a Randomized Controlled Trial." Ophthalmology. Glaucoma vol. (2021). doi: https://doi.org/10.1016/j.ogla.2021.04.006
Muir KW, Rosdahl JA, Hein AM, Woolson S, Olsen MK, Kirshner M, Sexton M, Bosworth HB. Improved Glaucoma Medication Adherence in a Randomized Controlled Trial. Ophthalmol Glaucoma. 2021 Apr 20; doi: 10.1016/j.ogla.2021.04.006. Epub 2021 Apr 20. PMID: 33892170.
Copy Download .nbib Format: NLM
Response to Sexual and Gender-Based Violence Against Women During COVID-19.

Indian journal of psychological medicine

Vranda MN, Febna M.
PMID: 33354090
Indian J Psychol Med. 2020 Nov 02;42(6):582-584. doi: 10.1177/0253717620966735. eCollection 2020 Nov.

No abstract available.

Cite
Vranda MN, Febna M. Response to Sexual and Gender-Based Violence Against Women During COVID-19. Indian J Psychol Med. 2020;42(6):582-584doi: 10.1177/0253717620966735.
Vranda, M. N., & Febna, M. (2020). Response to Sexual and Gender-Based Violence Against Women During COVID-19. Indian journal of psychological medicine, 42(6), 582-584. https://doi.org/10.1177/0253717620966735
Vranda, Mysore Narasimha, and Febna, Moorkath. "Response to Sexual and Gender-Based Violence Against Women During COVID-19." Indian journal of psychological medicine vol. 42,6 (2020): 582-584. doi: https://doi.org/10.1177/0253717620966735
Vranda MN, Febna M. Response to Sexual and Gender-Based Violence Against Women During COVID-19. Indian J Psychol Med. 2020 Nov 02;42(6):582-584. doi: 10.1177/0253717620966735. eCollection 2020 Nov. PMID: 33354090; PMCID: PMC7735227.
Copy Download .nbib Format: NLM
Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management.

Journal of personalized medicine

Butova X, Shayakhmetov S, Fedin M, Zolotukhin I, Gianesini S.
PMID: 34945749
J Pers Med. 2021 Dec 02;11(12). doi: 10.3390/jpm11121280.

Consultation prioritization is fundamental in optimal healthcare management and its performance can be helped by artificial intelligence (AI)-dedicated software and by digital medicine in general. The need for remote consultation has been demonstrated not only in the pandemic-induced lock-down...

Cite
Butova X, Shayakhmetov S, Fedin M, et al. Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management. J Pers Med. 2021;11(12)doi: 10.3390/jpm11121280.
Butova, X., Shayakhmetov, S., Fedin, M., Zolotukhin, I., & Gianesini, S. (2021). Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management. Journal of personalized medicine, 11(12), . https://doi.org/10.3390/jpm11121280
Butova, Xenia, et al. "Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management." Journal of personalized medicine vol. 11,12 (2021). doi: https://doi.org/10.3390/jpm11121280
Butova X, Shayakhmetov S, Fedin M, Zolotukhin I, Gianesini S. Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management. J Pers Med. 2021 Dec 02;11(12). doi: 10.3390/jpm11121280. PMID: 34945749.
Copy Download .nbib Format: NLM
Designing teacher professional development programs to support a rapid shift to digital.

Educational technology research and development : ETR & D

Heap T, Thompson R, Fein A.
PMID: 33223780
Educ Technol Res Dev. 2020 Nov 17;1-4. doi: 10.1007/s11423-020-09863-5. Epub 2020 Nov 17.

From a design perspective, this paper offers a response to the impact, value, and application of a manuscript published by Philipsen et al. (Improving teacher professional development for online and blended learning: A systematic meta-aggregative review. 

Cite
Heap T, Thompson R, Fein A. Designing teacher professional development programs to support a rapid shift to digital. Educ Technol Res Dev. 2020;1-4doi: 10.1007/s11423-020-09863-5.
Heap, T., Thompson, R., & Fein, A. (2020). Designing teacher professional development programs to support a rapid shift to digital. Educational technology research and development : ETR & D, 1-4. https://doi.org/10.1007/s11423-020-09863-5
Heap, Tania, et al. "Designing teacher professional development programs to support a rapid shift to digital." Educational technology research and development : ETR & D vol. (2020): 1-4. doi: https://doi.org/10.1007/s11423-020-09863-5
Heap T, Thompson R, Fein A. Designing teacher professional development programs to support a rapid shift to digital. Educ Technol Res Dev. 2020 Nov 17;1-4. doi: 10.1007/s11423-020-09863-5. Epub 2020 Nov 17. PMID: 33223780; PMCID: PMC7671574.
Copy Download .nbib Format: NLM
Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management.

Journal of personalized medicine

Butova X, Shayakhmetov S, Fedin M, Zolotukhin I, Gianesini S.
PMID: 34945749
J Pers Med. 2021 Dec 02;11(12). doi: 10.3390/jpm11121280.

Consultation prioritization is fundamental in optimal healthcare management and its performance can be helped by artificial intelligence (AI)-dedicated software and by digital medicine in general. The need for remote consultation has been demonstrated not only in the pandemic-induced lock-down...

Cite
Butova X, Shayakhmetov S, Fedin M, et al. Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management. J Pers Med. 2021;11(12)doi: 10.3390/jpm11121280.
Butova, X., Shayakhmetov, S., Fedin, M., Zolotukhin, I., & Gianesini, S. (2021). Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management. Journal of personalized medicine, 11(12), . https://doi.org/10.3390/jpm11121280
Butova, Xenia, et al. "Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management." Journal of personalized medicine vol. 11,12 (2021). doi: https://doi.org/10.3390/jpm11121280
Butova X, Shayakhmetov S, Fedin M, Zolotukhin I, Gianesini S. Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management. J Pers Med. 2021 Dec 02;11(12). doi: 10.3390/jpm11121280. PMID: 34945749.
Copy Download .nbib Format: NLM
Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department.

Pediatric emergency care

Khan MA, Rosenberg MG, Fein DM, Quezada XH, Reingold RE, Tadros FK, Wolnerman YY, Yao JY, Schneider C, Meltzer JA, Vorobeva E.
PMID: 31977776
Pediatr Emerg Care. 2021 Dec 01;37(12):e1315-e1320. doi: 10.1097/PEC.0000000000002030.

OBJECTIVES: Most children in the United States who visit the emergency department (ED) with fever have minor illnesses not requiring treatment or hospitalization. However, when a child has recently immigrated or traveled abroad, internationally acquired severe systemic infections (ISSIs)...

Cite
Khan MA, Rosenberg MG, Fein DM, et al. Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department. Pediatr Emerg Care. 2021;37(12):e1315-e1320doi: 10.1097/PEC.0000000000002030.
Khan, M. A., Rosenberg, M. G., Fein, D. M., Quezada, X. H., Reingold, R. E., Tadros, F. K., Wolnerman, Y. Y., Yao, J. Y., Schneider, C., Meltzer, J. A., & Vorobeva, E. (2021). Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department. Pediatric emergency care, 37(12), e1315-e1320. https://doi.org/10.1097/PEC.0000000000002030
Khan, Masrur A, et al. "Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department." Pediatric emergency care vol. 37,12 (2021): e1315-e1320. doi: https://doi.org/10.1097/PEC.0000000000002030
Khan MA, Rosenberg MG, Fein DM, Quezada XH, Reingold RE, Tadros FK, Wolnerman YY, Yao JY, Schneider C, Meltzer JA, Vorobeva E. Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department. Pediatr Emerg Care. 2021 Dec 01;37(12):e1315-e1320. doi: 10.1097/PEC.0000000000002030. PMID: 31977776.
Copy Download .nbib Format: NLM
Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department.

Pediatric emergency care

Khan MA, Rosenberg MG, Fein DM, Quezada XH, Reingold RE, Tadros FK, Wolnerman YY, Yao JY, Schneider C, Meltzer JA.
PMID: 31977776
Pediatr Emerg Care. 2021 Dec 01;37(12):e1315-e1320. doi: 10.1097/PEC.0000000000002030.

OBJECTIVES: Most children in the United States who visit the emergency department (ED) with fever have minor illnesses not requiring treatment or hospitalization. However, when a child has recently immigrated or traveled abroad, internationally acquired severe systemic infections (ISSIs)...

Cite
Khan MA, Rosenberg MG, Fein DM, et al. Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department. Pediatr Emerg Care. 2021;37(12):e1315-e1320doi: 10.1097/PEC.0000000000002030.
Khan, M. A., Rosenberg, M. G., Fein, D. M., Quezada, X. H., Reingold, R. E., Tadros, F. K., Wolnerman, Y. Y., Yao, J. Y., Schneider, C., & Meltzer, J. A. (2021). Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department. Pediatric emergency care, 37(12), e1315-e1320. https://doi.org/10.1097/PEC.0000000000002030
Khan, Masrur A, et al. "Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department." Pediatric emergency care vol. 37,12 (2021): e1315-e1320. doi: https://doi.org/10.1097/PEC.0000000000002030
Khan MA, Rosenberg MG, Fein DM, Quezada XH, Reingold RE, Tadros FK, Wolnerman YY, Yao JY, Schneider C, Meltzer JA. Internationally Acquired Severe Systemic Infections in Febrile Pediatric Travelers Presenting to the Emergency Department. Pediatr Emerg Care. 2021 Dec 01;37(12):e1315-e1320. doi: 10.1097/PEC.0000000000002030. PMID: 31977776.
Copy Download .nbib Format: NLM
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series.

The journal of allergy and clinical immunology. In practice

Picard M, Drolet JP, Masse MS, Filion CA, Al-Muhizi F, Fein M, Copaescu A, Isabwe GAC, Blaquière M, Primeau MN.
PMID: 34949564
J Allergy Clin Immunol Pract. 2021 Dec 08; doi: 10.1016/j.jaip.2021.11.021. Epub 2021 Dec 08.

No abstract available.

Cite
Picard M, Drolet JP, Masse MS, et al. Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.11.021.
Picard, M., Drolet, J. P., Masse, M. S., Filion, C. A., Al-Muhizi, F., Fein, M., Copaescu, A., Isabwe, G. A. C., Blaquière, M., & Primeau, M. N. (2021). Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.11.021
Picard, Matthieu, et al. "Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.11.021
Picard M, Drolet JP, Masse MS, Filion CA, Al-Muhizi F, Fein M, Copaescu A, Isabwe GAC, Blaquière M, Primeau MN. Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series. J Allergy Clin Immunol Pract. 2021 Dec 08; doi: 10.1016/j.jaip.2021.11.021. Epub 2021 Dec 08. PMID: 34949564.
Copy Download .nbib Format: NLM
Environmental implications of N-shaped environmental Kuznets curve for E7 countries.

Environmental science and pollution research international

Gyamfi BA, Adedoyin FF, Bein MA, Bekun FV.
PMID: 33635458
Environ Sci Pollut Res Int. 2021 Feb 26; doi: 10.1007/s11356-021-12967-x. Epub 2021 Feb 26.

The environmental Kuznets curve (EKC) hypothesis is of great importance to understanding the relationship between economic activity and environmental degradation. Given the current wave of climate change and environmental crisis traced to rising environmental pollution from economic activities, it...

Cite
Gyamfi BA, Adedoyin FF, Bein MA, et al. Environmental implications of N-shaped environmental Kuznets curve for E7 countries. Environ Sci Pollut Res Int. 2021;doi: 10.1007/s11356-021-12967-x.
Gyamfi, B. A., Adedoyin, F. F., Bein, M. A., & Bekun, F. V. (2021). Environmental implications of N-shaped environmental Kuznets curve for E7 countries. Environmental science and pollution research international, . https://doi.org/10.1007/s11356-021-12967-x
Gyamfi, Bright Akwasi, et al. "Environmental implications of N-shaped environmental Kuznets curve for E7 countries." Environmental science and pollution research international vol. (2021). doi: https://doi.org/10.1007/s11356-021-12967-x
Gyamfi BA, Adedoyin FF, Bein MA, Bekun FV. Environmental implications of N-shaped environmental Kuznets curve for E7 countries. Environ Sci Pollut Res Int. 2021 Feb 26; doi: 10.1007/s11356-021-12967-x. Epub 2021 Feb 26. PMID: 33635458.
Copy Download .nbib Format: NLM
Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma.

Nuclear medicine and molecular imaging

Nguyen XC, Lee WW, Amin AM, Eo JS, Bang SM, Lee JS, Kim SE.
PMID: 24899936
Nucl Med Mol Imaging. 2010 Apr;44(1):39-44. doi: 10.1007/s13139-009-0009-0. Epub 2010 Feb 26.

PURPOSE: It is uncertain whether the tumor burden as assessed using FDG-PET has prognostic significance in newly diagnosed diffuse large B-cell lymphoma (DLBCL). The authors undertook this study to determine whether a parameter that reflects both FDG uptake magnitude...

Cite
Nguyen XC, Lee WW, Amin AM, et al. Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma. Nucl Med Mol Imaging. 2010;44(1):39-44doi: 10.1007/s13139-009-0009-0.
Nguyen, X. C., Lee, W. W., Amin, A. M., Eo, J. S., Bang, S. M., Lee, J. S., & Kim, S. E. (2010). Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma. Nuclear medicine and molecular imaging, 44(1), 39-44. https://doi.org/10.1007/s13139-009-0009-0
Nguyen, Xuan Canh, et al. "Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma." Nuclear medicine and molecular imaging vol. 44,1 (2010): 39-44. doi: https://doi.org/10.1007/s13139-009-0009-0
Nguyen XC, Lee WW, Amin AM, Eo JS, Bang SM, Lee JS, Kim SE. Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma. Nucl Med Mol Imaging. 2010 Apr;44(1):39-44. doi: 10.1007/s13139-009-0009-0. Epub 2010 Feb 26. PMID: 24899936; PMCID: PMC4042962.
Copy Download .nbib Format: NLM
[What can be expected of a Cancer Detection Center?].

Therapeutische Umschau. Revue therapeutique

Fehr AM.
PMID: 5612682
Ther Umsch. 1967 Jul;24(7):275-7.

No abstract available.

Cite
Fehr AM. Was kann man von einem Cancer Detection Center erwarten. [What can be expected of a Cancer Detection Center?]. Ther Umsch. 1967;24(7):275-7
Fehr, A. M. (1967). Was kann man von einem Cancer Detection Center erwarten. [What can be expected of a Cancer Detection Center?]. Therapeutische Umschau. Revue therapeutique, 24(7), 275-7.
Fehr, A M. "Was kann man von einem Cancer Detection Center erwarten." [What can be expected of a Cancer Detection Center?]. Therapeutische Umschau. Revue therapeutique vol. 24,7 (1967): 275-7.
Fehr AM. Was kann man von einem Cancer Detection Center erwarten. [What can be expected of a Cancer Detection Center?]. Ther Umsch. 1967 Jul;24(7):275-7. German. PMID: 5612682.
Copy Download .nbib Format: NLM
A human liver chimeric mouse model for non-alcoholic fatty liver disease.

JHEP reports : innovation in hepatology

Bissig-Choisat B, Alves-Bezerra M, Zorman B, Ochsner SA, Barzi M, Legras X, Yang D, Borowiak M, Dean AM, York RB, Galvan NTN, Goss J, Lagor WR, Moore DD, Cohen DE, McKenna NJ, Sumazin P, Bissig KD.
PMID: 34036256
JHEP Rep. 2021 Mar 21;3(3):100281. doi: 10.1016/j.jhepr.2021.100281. eCollection 2021 Jun.

BACKGROUND & AIMS: The accumulation of neutral lipids within hepatocytes underlies non-alcoholic fatty liver disease (NAFLD), which affects a quarter of the world's population and is associated with hepatitis, cirrhosis, and hepatocellular carcinoma. Despite insights gained from both human...

Cite
Bissig-Choisat B, Alves-Bezerra M, Zorman B, et al. A human liver chimeric mouse model for non-alcoholic fatty liver disease. JHEP Rep. 2021;3(3):100281doi: 10.1016/j.jhepr.2021.100281.
Bissig-Choisat, B., Alves-Bezerra, M., Zorman, B., Ochsner, S. A., Barzi, M., Legras, X., Yang, D., Borowiak, M., Dean, A. M., York, R. B., Galvan, N. T. N., Goss, J., Lagor, W. R., Moore, D. D., Cohen, D. E., McKenna, N. J., Sumazin, P., & Bissig, K. D. (2021). A human liver chimeric mouse model for non-alcoholic fatty liver disease. JHEP reports : innovation in hepatology, 3(3), 100281. https://doi.org/10.1016/j.jhepr.2021.100281
Bissig-Choisat, Beatrice, et al. "A human liver chimeric mouse model for non-alcoholic fatty liver disease." JHEP reports : innovation in hepatology vol. 3,3 (2021): 100281. doi: https://doi.org/10.1016/j.jhepr.2021.100281
Bissig-Choisat B, Alves-Bezerra M, Zorman B, Ochsner SA, Barzi M, Legras X, Yang D, Borowiak M, Dean AM, York RB, Galvan NTN, Goss J, Lagor WR, Moore DD, Cohen DE, McKenna NJ, Sumazin P, Bissig KD. A human liver chimeric mouse model for non-alcoholic fatty liver disease. JHEP Rep. 2021 Mar 21;3(3):100281. doi: 10.1016/j.jhepr.2021.100281. eCollection 2021 Jun. PMID: 34036256; PMCID: PMC8138774.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 128 entries